Neutrophil-lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC)

被引:23
|
作者
Xiang, Zi-jun [1 ]
Hu, Tao [2 ]
Wang, Yun [1 ]
Wang, Hao [1 ]
Xu, Lin [3 ]
Cui, Ning [3 ]
机构
[1] Taihe Hosp, Ctr Liver Biliary Pancreat, Shiyan City, Hubei, Peoples R China
[2] Zhuxi Peoples Hosp, Dept Radiol, Shiyan City, Hubei, Peoples R China
[3] Taihe Hosp, Med Imaging Ctr Intervent Room, Shiyan City, Hubei, Peoples R China
关键词
CANCER; RESECTION; CYTOKINES; SURVIVAL; CELLS; INDEX;
D O I
10.1042/BSR20201190
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although the oncological outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) have markedly improved over the past decade, the survival prediction is still challenging. The aim of this study was to investigate the prognostic value of neutrophil-lymphocyte ratio (NLR) and analyze the relationship of between the NLR and immune cells phenotypes in patients with PDAC. Sixty-seven consecutive patients with PDAC were recruited in this study. Life-table estimates of survival time were calculated according to the Kaplan and Meier methodology. The phenotypic T cells subclasses were evaluated by flow cytometry. All the 67 patients in this study were treated with surgical resection and among them, 46 patients received adjuvant chemotherapy. Receiver operating characteristic (ROC) curves analysis was performed to compare prognostic value of NLR with CA199. We found that the Harrell's area under ROC (AUROC) for the NLR to predict overall survival (OS) (0.840; 95% CI, 0.766-0.898) was significantly higher than that of the CA199 levels. After that we stratified all patients into NLR > 2.5 (n = 42) and NLR <= 2.5 (n = 25) groups according to the OS of patients with PDAC. Survival analysis showed that patients with NLR <= 2.5 had significantly favorable OS and progressive free survival (PFS) compared with patients with NLR 2.5. The CD3+ and CD8+/CD28+ T cell subsets were significantly increased in patients with NLR <= 2.5 (P< 0.05), while the CD8+/CD28- and CD4+/CD25+ cell subsets were significantly decreased in patients with NLR <= 2.5 (P., 0.05). In conclusion, a high NLR value independently predicts poor survival in patients with PDAC after surgical resection. The NLR was closely related with immune cells phenotypes The NLR may help oncologists evaluate outcomes of patients received surgical resection and chemotherapy to choose alternative therapies for patients with high NLR value.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT
    Alagappan, Muthuraman
    Pollom, Erqi L.
    von Eyben, Rie
    Kozak, Margaret M.
    Aggarwal, Sonya
    Poultsides, George A.
    Koong, Albert C.
    Chang, Daniel T.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (03): : 242 - 247
  • [2] Prognosis of baseline absolute lymphocyte count (ALC) and neutrophil to lymphocyte ratio (NLR) in patients with pancreatic adenocarcinoma
    Anand, Kartik
    Borazanci, Erkut
    Pai, Sachin
    Shi, Runhua
    Jafri, Syed H.
    Mills, Glenn
    CANCER RESEARCH, 2015, 75
  • [3] Validation of the Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor of Overall Survival in a Cohort of Patients With Pancreatic Ductal Adenocarcinoma
    Ben, Qiwen
    An, Wei
    Wang, Lifu
    Wang, Weiyi
    Yu, Lei
    Yuan, Yaozong
    PANCREAS, 2015, 44 (03) : 471 - 477
  • [4] Prognostic Factors in Resected Pancreatic Ductal Adenocarcinoma: Is Neutrophil-Lymphocyte Ratio a Useful Marker?
    Merlo, Ignacio
    Ardiles, Victoria
    Sanchez-Claria, Rodrigo
    Fratantoni, Eugenia
    de Santibanes, Eduardo
    Pekolj, Juan
    Mazza, Oscar
    de Santibanes, Martin
    JOURNAL OF GASTROINTESTINAL CANCER, 2023, 54 (02) : 580 - 588
  • [5] Prognostic Factors in Resected Pancreatic Ductal Adenocarcinoma: Is Neutrophil-Lymphocyte Ratio a Useful Marker?
    Ignacio Merlo
    Victoria Ardiles
    Rodrigo Sanchez-Clariá
    Eugenia Fratantoni
    Eduardo de Santibañes
    Juan Pekolj
    Oscar Mazza
    Martín de Santibañes
    Journal of Gastrointestinal Cancer, 2023, 54 : 580 - 588
  • [6] Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio
    Bhatti, Imran
    Peacock, Oliver
    Lloyd, Gareth
    Larvin, Michael
    Hall, Richard I.
    AMERICAN JOURNAL OF SURGERY, 2010, 200 (02): : 197 - 203
  • [7] Neutrophil-Lymphocyte Ratio and Tumor Interface Response as Predictors of Outcomes for Prospective Cohort of Patients with Pancreatic Ductal Adenocarcinoma
    Thunshelle, C. P.
    Zaid, M.
    Jaoude, J. Abi
    Chowdhury, T.
    Dai, A.
    Kouzy, R.
    Mathew, R.
    Prakash, L.
    Katz, M. H. G.
    Varadhachary, G. R.
    Tamm, E. P.
    Minsky, B. D.
    Holliday, E., Jr.
    Das, P.
    Smith, G. L.
    Herman, J. M.
    Koong, A. C.
    Taniguchi, C. M.
    Koay, E. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E618 - E618
  • [8] The derived neutrophil-lymphocyte ratio and the neutrophil-lymphocyte ratio are related to poor prognosis in Hodgkin lymphoma patients
    Shen, Qian-Qing
    Gao, Jie
    Tao, Huan
    Wang, Shuo-Ting
    Wang, Fu-Jue
    Chen, Ying-Ying
    Zhang, Xue
    Jia, Yong-Qian
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2021, 11 (01): : 100 - 110
  • [9] The role of neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) andmonocyte - lymphocyte ratio (MLR) in prognosis of breast cancer patients
    Huszno, J.
    Kolosza, Z.
    Kwarciak, J. Mrochem
    Rutkowski, T.
    Skladowski, K.
    CANCER RESEARCH, 2019, 79 (04)
  • [10] Preoperative Independent Prognostic Factors in Patients With "Resectable" Pancreatic Ductal Adenocarcinoma Following Curative Resection: Neutrophil-lymphocyte Ratio and Platelet-Lymphocyte Ratio
    Asari, S.
    Toyama, H.
    Goto, T.
    Terai, S.
    Ajiki, T.
    Matsumoto, T.
    Shinozaki, K.
    Kido, M.
    Takebe, A.
    Tanaka, M.
    Kuramitsu, K.
    Kinoshita, H.
    Fukumoto, T.
    Ku, Y.
    PANCREAS, 2015, 44 (08) : 1360 - 1360